A total of 480 recent clinical isolates were tested for their suscepti
bility to fleroxacin, norfloxacin, ofloxacin, gentamicin, piperacillin
, cefoxitin, cefotaxime and imipenem. Fleroxacin showed potent activit
y against strains of Enterobacteriaceae, Acinetobacter spp. and gentam
icin-sensitive Pseudomonas aeruginosa with MIC90s ranging from 0.06 to
2 mg/l, although the MIC90 for gentamicin-resistant P. aeruginosa str
ains was as high as 32 mg/l. The drug exhibited excellent activity aga
inst staphylococci, both methicillin-sensitive and resistant. The over
all activity of fleroxacin was comparable with that of norfloxacin and
ofloxacin and higher than that exhibited by gentamicin and beta-lacta
m antibiotics tested.